Literature DB >> 3260754

Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle.

K Komori1, R R Lorenz, P M Vanhoutte.   

Abstract

The effects of nitric oxide and acetylcholine (ACh) were investigated on the electrical and mechanical properties of vascular smooth muscle cells of the canine mesenteric artery. Isolated tissues with or without the endothelium were contracted with prostaglandin F2 alpha. Nitric oxide caused comparable concentration-dependent relaxations in rings with and without endothelium. ACh induced concentration-dependent relaxations only in arteries with endothelium. The relaxations to both nitric oxide and ACh were inhibited by methylene blue or oxyhemoglobin. Either in the presence or absence of prostaglandin F2 alpha, ACh caused transient hyperpolarization of the cell membrane of the vascular smooth muscle. The ACh-induced transient hyperpolarization was not observed after mechanical removal of the endothelial cells or after treatment with atropine. Nitric oxide (less than or equal to 8 X 10(-6) M) did not alter membrane potential, in either the presence or absence of the endothelium. The excitatory junction potentials generated by perivascular nerve stimulation were inhibited by ACh but not by nitric oxide. These results suggest that in the canine mesenteric artery 1) the endothelium-derived hyperpolarizing factor generated by ACh is not nitric oxide; 2) nitric oxide relaxes vascular smooth muscle by a direct effect; and 3) nitric oxide does not modify adrenergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260754     DOI: 10.1152/ajpheart.1988.255.1.H207

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  49 in total

1.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

2.  Endothelium-dependent calcium-induced relaxation in the presence of Ca2+-antagonists in canine depolarized coronary arteries.

Authors:  K Kikkawa; S Murata; T Nagao
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Electrical responses of coronary artery smooth muscle associated with the cardiac muscle action potential in the monkey.

Authors:  F Mekata
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

4.  Role of K+ channels in EDHF-dependent relaxation induced by acetylcholine in canine coronary artery.

Authors:  Y Nakashima; Y Toki; Y Fukami; M Hibino; K Okumura; T Ito
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

5.  Uric acid as radical scavenger and antioxidant in the heart.

Authors:  B F Becker; N Reinholz; T Ozçelik; B Leipert; E Gerlach
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

6.  Cyclic GMP-independent relaxation and hyperpolarization with acetylcholine in guinea-pig coronary artery.

Authors:  D M Eckman; J S Weinert; I L Buxton; K D Keef
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.

Authors:  M D Randall; H Ujiie; T M Griffith
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Effect of 5-hydroxytryptamine on the membrane potential of endothelial and smooth muscle cells in the pig coronary artery.

Authors:  M Frieden; J L Bény
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

9.  Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.

Authors:  C E Bryant; G H Allcock; T D Warner
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery.

Authors:  S Illiano; T Nagao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.